248 related articles for article (PubMed ID: 15880380)
1. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
2. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
3. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
4. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.
Güre AO; Stockert E; Scanlan MJ; Keresztes RS; Jäger D; Altorki NK; Old LJ; Chen YT
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4198-203. PubMed ID: 10760287
[TBL] [Abstract][Full Text] [Related]
5. SOX1 autoantibodies: tumor markers in LEMS patients?
Lang B; Evoli A
Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
[No Abstract] [Full Text] [Related]
6. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
7. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
8. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
9. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
Maddison P; Thorpe A; Silcocks P; Robertson JF; Chapman CJ
Lung Cancer; 2010 Dec; 70(3):335-9. PubMed ID: 20371131
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer.
Bataller L; Wade DF; Graus F; Stacey HD; Rosenfeld MR; Dalmau J
Neurology; 2004 Mar; 62(5):778-82. PubMed ID: 15007130
[TBL] [Abstract][Full Text] [Related]
12. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
13. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
[TBL] [Abstract][Full Text] [Related]
14. Anti-survivin antibody responses in lung cancer.
Karanikas V; Khalil S; Kerenidi T; Gourgoulianis KI; Germenis AE
Cancer Lett; 2009 Sep; 282(2):159-66. PubMed ID: 19380192
[TBL] [Abstract][Full Text] [Related]
15. Serum p53 antibodies: predictors of survival in small-cell lung cancer?
Murray PV; Soussi T; O'Brien ME; Smith IE; Brossault S; Norton A; Ashley S; Tavassoli M
Br J Cancer; 2000 Dec; 83(11):1418-24. PubMed ID: 11076647
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.
Lee HR; Lennon VA; Camilleri M; Prather CM
Am J Gastroenterol; 2001 Feb; 96(2):373-9. PubMed ID: 11232678
[TBL] [Abstract][Full Text] [Related]
17. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum.
Vangsted AJ; Clausen H; Kjeldsen TB; White T; Sweeney B; Hakomori S; Drivsholm L; Zeuthen J
Cancer Res; 1991 Jun; 51(11):2879-84. PubMed ID: 1851663
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
[TBL] [Abstract][Full Text] [Related]
20. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
